Detail akcie SurModics online

Business Summary: Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Financial Summary: BRIEF: For the six months ended 31 March 2025, Surmodics Inc revenues decreased 7% to $58M. Net loss increased from $539K to $8.9M. Revenues reflect Medical Device segment decrease of 9% to $44M, In Vitro Diagnostics segment decrease of 1% to $14M. Higher net loss reflects Corporate segment loss increase of 78% to $11M, Medical Device segment loss totaling $1.7M vs. income of $78K, In Vitro Diagnostics segment income decrease of 3% to $6.3M.